Search

Certara Inc

Slēgts

SektorsVeselības aprūpe

9.08 1.91

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.08

Max

9.19

Galvenie mērījumi

By Trading Economics

Ienākumi

-380K

-9.1M

Pārdošana

-14M

93M

P/E

Sektora vidējais

100.714

55.725

EPS

0.05

Peļņas marža

-9.803

Darbinieki

1,515

EBITDA

-4.2M

12M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-11.09% downside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

27M

1.3B

Iepriekšējā atvēršanas cena

7.17

Iepriekšējā slēgšanas cena

9.08

Ziņu noskaņojums

By Acuity

50%

50%

113 / 339 Rangs Healthcare

Certara Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 25. sept. 20:07 UTC

Certara Inc is advancing, rebounding from an earlier pullback and gaining ground since Thursday's close, amid solid broader market performance.

2026. g. 24. sept. 19:51 UTC

Certara Inc is trading higher, rebounding from an earlier low and maintaining strength above its 20-day moving average during Thursday's session.

2026. g. 23. sept. 20:07 UTC

Certara Inc shares fell sharply after an initial spike, dropping significantly below Tuesday's close despite remaining above its 20-day moving average.

2026. g. 22. sept. 21:01 UTC

Certara Inc is declining in after-market trading, falling sharply below Tuesday's close despite being above its 20-day moving average.

2026. g. 21. sept. 23:25 UTC

Certara Inc is trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026. g. 18. sept. 20:07 UTC

Certara Inc's stock is declining, having pulled back from an earlier peak, and remains lower compared to Thursday's close while trading above its 20-day moving average.

2026. g. 17. sept. 23:31 UTC

Certara Inc is rising in after-market trading, reaching a peak shortly after the market closed, significantly above its 20-day moving average.

2026. g. 16. sept. 22:01 UTC

Certara Inc is seeing a slight uptick in after-market trading, recovering from a brief dip to achieve a modest gain within its one-month trading range.

2026. g. 15. sept. 20:01 UTC

Certara Inc shares are higher during Tuesday's session, diverging from broader market sentiment impacted by a decline in the NY Empire State Manufacturing Index.

2026. g. 14. sept. 19:51 UTC

Certara Inc shares are trading higher, continuing a recent upward trend. No specific news was identified to explain this price movement.

2026. g. 10. sept. 20:07 UTC

Shares of Certara Inc. are trading lower today, reflecting broader market trends amid five consecutive sessions of declines and pressure from recent interest rate hikes.

2026. g. 9. sept. 20:07 UTC

Certara Inc. shares are lower today, breaking the upward trend seen since Tuesday's close. No specific news or development was identified.

2026. g. 8. sept. 19:41 UTC

Certara Inc is lower today, impacted by weakness in the Health Care Technology sub-sector. The stock remains below its 20-day moving average.

2026. g. 3. sept. 20:07 UTC

Certara Inc shares are lower today, continuing a decline since Wednesday amid a broader downturn in the health care technology sector.

2026. g. 1. sept. 20:08 UTC

Certara Inc shares are lower today, continuing a downward trend from earlier sessions and remaining below the 20-day moving average.

2026. g. 31. aug. 22:02 UTC

Shares of Certara Inc. are trading lower during after-market hours, reversing a trend of higher daily closes. No specific news was identified.

2026. g. 27. aug. 20:01 UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

2026. g. 26. aug. 19:56 UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

2026. g. 25. aug. 20:51 UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

2026. g. 24. aug. 20:01 UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

2026. g. 21. aug. 19:56 UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

2026. g. 20. aug. 20:06 UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

2026. g. 19. aug. 23:56 UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

2026. g. 18. aug. 19:36 UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

2026. g. 13. aug. 19:41 UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

2026. g. 12. aug. 19:46 UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

2026. g. 11. aug. 23:51 UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

2026. g. 7. aug. 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

2026. g. 6. aug. 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

2026. g. 5. aug. 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

Salīdzinājums

Cenas izmaiņa

Certara Inc Prognoze

Cenas mērķis

By TipRanks

-11.09% uz leju

Prognoze 12 mēnešiem

Vidējais 8.1 USD  -11.09%

Augstākais 9 USD

Zemākais 7 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Certara Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

7 ratings

1

Pirkt

6

Turēt

0

Pārdot

Noskaņojums

By Acuity

113 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.